FDA declines to review Moderna’s mRNA flu vaccine

The FDA has declined to review Moderna’s application for its mRNA flu vaccine, mRNA-1010, surprising the company. This decision is part of a broader trend of resistance towards vaccines, especially mRNA types, under the leadership of anti-vaccine advocate Robert F. Kennedy Jr., who has cut childhood vaccine recommendations and canceled significant funding for mRNA research. The FDA’s rejection was specifically related to the design of Moderna’s Phase 3 trial and the comparator vaccine used.

Want More Context? 🔎